Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features
about
Melanoma brain metastases: an unmet challenge in the era of active therapyManaging leptomeningeal melanoma metastases in the era of immune and targeted therapy.[Melanoma brain metastases : Treatment options].Melanoma brain metastases: correlation of imaging features with genomic markers and patient survival.Prognostic indices for brain metastases--usefulness and challengesThe long noncoding RNA SPRIGHTLY acts as an intranuclear organizing hub for pre-mRNA moleculesA rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature.Melanoma leptomeningeal dissemination following frontoparietal metastasis surgery: Case report and review of the literature.Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic targetDabrafenib and its potential for the treatment of metastatic melanoma.Patients undergoing surgery of intracranial metastases have different outcomes based on their primary pathology.Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survivalWhy does Jack, and not Jill, break his crown? Sex disparity in brain tumorsA Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases.Survival over 6 years in a patient with brain metastases from melanoma treated with temozolomideImpact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on the brain distribution of a novel BRAF inhibitor: vemurafenib (PLX4032)Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases.Carcinomatous meningitis: Leptomeningeal metastases in solid tumorsIntracranial Tumor Cell Migration and the Development of Multiple Brain Metastases in Malignant Melanoma.Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brainIpilimumab and whole brain radiation therapy for melanoma brain metastases.Brain metastases: a medical neuro-oncology perspective.Single brain metastases from melanoma: remarks on a series of 84 patients.Chemoprevention for brain metastases.A systematic approach to the management of patients with brain metastases of known or unknown primary site.Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.Melanoma brain metastasis: overview of current management and emerging targeted therapies.Dabrafenib therapy for advanced melanoma.Whole-brain radiotherapy in patients with brain metastases from melanoma.The current management of brain metastasis in melanoma: a focus on riluzole.Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.En Bloc Resection of Desmoplastic Neurotropic Melanoma with Perineural Invasion of the Intracranial Trigeminal and Intraparotid Facial Nerve: Case Report and Review of the Literature.Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.Melanoma central nervous system metastases: current approaches, challenges, and opportunities.Incidence of seizure in adult patients with intracranial metastatic disease.Targeted Treatment of Brain Metastases.Challenges in the delivery of therapies to melanoma brain metastases.Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab.Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report.The role of radiation therapy in the management of metastatic melanoma in the brain.
P2860
Q26995622-8DE1DE36-692F-4205-8948-A1ACC9023C1DQ30251581-79635D98-6983-4EC4-99FD-7148A426DF43Q31098294-6E8ACC45-43B4-43FF-851E-6D8253AB5FA7Q31141368-001FCF2D-5F2B-4082-9362-1593F32CBCF4Q33414874-B9CFF2D2-F699-479B-A4EF-2DCF77B52F68Q33633347-6AEF2FAD-CCD1-4359-AE82-672B604BBC40Q33885560-5BF8686B-FAED-4EF5-996D-2F86E990C579Q34368666-4510EBE2-B103-4426-991B-A4944E66DA0BQ34438536-7A159626-5620-4370-9262-63761F1681ABQ34646614-5E498A25-6C7A-4576-8F38-CE76A1E0CEDBQ35000133-EDAF364D-3AD8-4AB5-9DDA-3400E5D92192Q35050763-0AD1DED9-99CE-4426-9415-DFFDFB76EE6EQ35802422-5FEF43D5-CD40-4409-936F-2F510B8F6319Q35820476-BE829AAA-1982-44F8-8835-D6C5EF70E667Q35980450-47FEAC4E-D068-4C4F-A50E-88095B6F0BFFQ36057973-AF5DED86-B408-40BB-AAA7-B482B517148BQ36370362-176D16D6-31E1-4CEB-9471-2C282088061BQ36851197-67B5E2D4-EA82-45E1-8808-288C02C96A23Q37004553-B5FB30BB-8ACF-45BB-A81A-13C9061D3205Q37078733-F53CEDAE-387A-4D42-B481-6D11287BF279Q37114636-472D9EF4-2160-433B-8495-888A6A116D67Q37724219-21303633-A330-4D31-B142-4A7BADCDA475Q37931706-622D134C-5E0C-4751-820C-592AB4CB824CQ37946748-6967B40D-7210-4BDD-98CB-B3F1221E4A73Q37951389-214CF6EC-732F-4351-BCDE-11CC06A54786Q38010057-454BBB24-515A-4AFB-8AD4-3698C37693A8Q38053444-B7ED286C-B4EB-450F-9AFB-CB8551F9010BQ38164679-8B8C553E-8346-4F91-9A34-4907F4E5709DQ38273427-C14BA7F2-D094-443B-B2A7-803EEFC5B4D9Q38532696-1B1176F8-2FA7-42DE-B8A5-5C3429941C69Q38737680-F7A8C52D-FB1E-46BB-A46E-96BF2FD24E3FQ38756217-A6A436DB-39E0-4D66-BC5A-2CA4EA6097EBQ38775281-027C729C-0F01-4082-9A7E-C1C4054C8F2AQ38807942-82296B65-BFA5-400C-B8B4-6E30F4E85CB8Q39017688-125B98E9-7314-4009-92D0-C7E06AE8B87DQ39192200-2A7BD4D7-44F7-49FD-BFA7-0A10BB5FB29BQ39331752-B4312088-9045-4BEE-B6D5-915772D00B2CQ40382284-8AEC1882-B88F-48ED-8AE0-030424243054Q41199889-17D9B1CA-278B-4C51-A2E6-DE88CA6739B8Q42535832-BE5D9448-8395-4B87-AE0F-30E675DEBA9E
P2860
Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Brain and leptomeningeal metas ...... mes based on clinical features
@en
Brain and leptomeningeal metas ...... es based on clinical features.
@nl
type
label
Brain and leptomeningeal metas ...... mes based on clinical features
@en
Brain and leptomeningeal metas ...... es based on clinical features.
@nl
prefLabel
Brain and leptomeningeal metas ...... mes based on clinical features
@en
Brain and leptomeningeal metas ...... es based on clinical features.
@nl
P2093
P2860
P1433
P1476
Brain and leptomeningeal metas ...... mes based on clinical features
@en
P2093
Andrew Wilton
Caroline von Althann
Drew E Baldwin
Elizabeth Bailey
Gladys Alvarado
Jeffrey J Raizer
Katherine S Panageas
Lynne A Lamb
Mark H Bilsky
Philip H Gutin
P2860
P304
P356
10.1215/15228517-2007-058
P577
2008-02-20T00:00:00Z